Maintaining Hold: Both Re-Engagement Triggers Hit, and a 16% Single-Session Re-Rating Took the Whole Prize

Results vs. Consensus

Q4 FY2026 Scorecard

Two bars mattered in this print and Accenture cleared both. Consensus sat at roughly $18.03B of revenue and $3.18 of EPS, and the quarter came in at $18,679.1M and $3.29. The more informative bar was management's own: the Q4 range set in June was $17.75B to $18.40B, or 1% to 5% growth in local currency, and management attached an unusual caveat to it, warning that "more of the range is in play" as discretionary spending softened in the closing weeks of Q3. Revenue landed above the ceiling of that range at +7% local currency. A company that guides conservatively and then warns the low end is live does not usually print above the high end three months later.

Year-Over-Year Comparisons

The GAAP-versus-adjusted distinction matters more than usual this quarter. Q4 FY2025 carried the entire $615.3M business-optimization charge that defined last year's fourth quarter, so GAAP EPS moved from $2.25 to $3.29, a 46% increase that means nothing. The honest comparison is against Q4 FY2025 adjusted EPS of $3.03, which makes this a 9% increase, and against adjusted operating margin of 15.1%, which makes this 20 basis points of expansion. Both are good numbers. Neither is a 46% anything.

Quarter-Over-Quarter Comparisons

Read the sequential table carefully, because the headline numbers invert the story the quarter actually tells. Revenue was flat sequentially and EPS fell 13%, both of which are normal: Q4 gross margin structurally steps down from Q3, and the 80 basis points of sequential compression here closely tracks the 100 basis points Q4 FY2025 gave up against Q3 FY2025. What is not seasonal is the bookings reversal, from $19.3B at a 1.0x book-to-bill to $22.17B at 1.2x. That is the single most important number in the release, and it is the one that moves the rating off its June footing.

Full-Year FY2026

Against the guidance management gave in June, every line in the right-hand column is a beat except adjusted operating margin, which landed exactly on its 15.8% guide, and acquisition spend. Revenue finished at +5% local currency against a +3% to +4% guide. Adjusted EPS of $13.97 cleared the $13.78 to $13.90 range. Free cash flow of $11.62B came in above the $11.5B ceiling, and FCF conversion held at 1.4x rather than the guided 1.3x. The capital return of $11.5B blew through the "at least $9.5B" commitment by $2B, which is exactly the size of the incremental fourth-quarter buyback. The CFO's framing was accurate and unusually unhedged: "For the full year, we achieved or exceeded all aspects of our original guidance while returning a record level of cash to shareholders."

The quarterly revenue figures tie to the full year without residual: $18,742.1M plus $18,044.1M plus $18,718.1M plus $18,679.1M equals the reported $74,183.4M. Acquisition spend fell short only on timing: roughly $3B of the cyber operational-technology transactions, Dragos included, slipped from Q4 into September on regulatory clearance and now lands in Q1 FY2027.

Revenue

Seven percent local-currency growth with every geographic market at exactly 7% and every industry group positive is the broadest quarter Accenture has printed in the window we cover. That breadth is the genuine surprise. For four quarters the story has been a narrowing one, with growth concentrated in Communications, Media and Technology and in managed services while consulting and the discretionary industries lagged. This quarter, Americas, EMEA, and Asia Pacific all grew 7% in local currency, and consulting grew 7% against managed services' 7%. The federal business, which subtracted roughly a full point from FY2026 revenue, sunset its drag at the end of Q3 and actually contributed to the Q4 over-delivery. Strip the one-time capacity help from PTO carry-forward and the underlying rate is still comfortably above the guided range. What breadth does not tell you is durability, and management's own demand commentary says nothing structural changed.

Margins

Gross margin at 32.0% against 31.9% is a 10 basis point expansion, and the identical figure holds for the full year. This is the metric our December 2025 upgrade was built on, the metric whose reversal in June broke it, and it has now turned back up. It also expanded while absorbing the largest investment year in the company's recent history. The honest caveat is magnitude: 10 basis points is inside the noise band for a business this size, and the CFO deliberately redirected attention away from it, arguing that "the best way to look at us is the guidance that we give for op margin." Operating margin is the cleaner number, and at 15.8% adjusted for the full year, up 20 basis points, it landed in the middle of the guided 10-to-30 basis point range. Asia Pacific is the blemish: fourth-quarter operating margin of 14% against 18% adjusted a year ago, with operating income down 17% on revenue up 3%.

EPS

Adjusted EPS of $13.97 for the year, up 8%, against revenue up 5% in local currency, is three points of leverage from margin, share count, and mix, partially given back to a 130 basis point higher tax rate. The composition is deteriorating in a way that matters for FY2027. Weighted average diluted shares fell 2.4% for the year and 3.8% in the fourth quarter, so buyback is doing a growing share of the work. Net interest, meaning interest income less interest expense, flipped from $39.0M of income in Q4 FY2025 to a $0.4M expense in Q4 FY2026, the first negative net-interest quarter in years, and that is on roughly seven weeks of the $5B issuance. FY2027 carries twelve months of a $10.0B long-term debt balance. The company's own FY2027 EPS guide of 3% to 6% growth over adjusted FY2026, against 3% to 6% revenue growth and 10 to 30 basis points of margin expansion and a 3% share-count reduction, is the arithmetic confession: interest and tax absorb essentially all the operating leverage.

Segment Performance

By Type of Work — Q4 FY2026

Consulting — the revenue line finally caught up, the bookings line did not

Consulting revenue of $9.28B grew 7% in local currency, matching managed services for the first time in roughly eighteen quarters by the Street's count. That is the single most encouraging datapoint in the segment tables, because consulting is the discretionary, higher-rate, project-based half of Accenture and the half the AI-cannibalization thesis is actually about. For the full year consulting grew only 3% in local currency against managed services' 6%, so a quarter at parity is a genuine inflection in the mix.

The bookings side did not cooperate. Consulting new bookings of $9.40B produced a 1.0x book-to-bill, down from 1.1x in Q3 and from the 1.3x and $11.3B that made the Q2 FY2026 print a record. Against the year-ago quarter the comparison is better than it looks: Q4 FY2025 consulting bookings were $8.9B, also at 1.0x, so consulting bookings grew about 6% year over year and the 1.0x reading is the normal fourth-quarter shape rather than a fresh deterioration. But a 1.0x book-to-bill does not build backlog, and backlog is what funds FY2027 consulting revenue.

"One of the things that we're seeing, David, is that in our managed services business our clients are really using managed services to transform as well as get certainty around business outcomes. We're seeing a lot of consulting, even in our managed services deals."
— Julie Sweet, Chair & CEO

Assessment: management's explanation for consulting's revenue strength is that consulting work is increasingly being delivered inside managed-services contracts, which is both plausible and convenient. If true, the consulting revenue line will keep improving while the consulting bookings line stays near 1.0x, because the demand is being booked as managed services. That is a mix shift toward longer-duration, outcome-priced, lower-rate work. It is more durable and less profitable. For FY2027, management guided both consulting and managed services to land inside the 3% to 6% range, which is the first time in the window we cover that consulting has not been guided below the company.

Managed Services — a record quarter, and structurally the Q4 engine

Managed-services bookings of $12.77B at a 1.4x book-to-bill were a company record, surpassing the prior record set in Q4 FY2025. Revenue of $9.40B grew 7% in both US dollars and local currency, driven by high-single-digit growth in technology managed services, which covers application and infrastructure management, and high-single-digit growth in operations. Managed services also crossed consulting in absolute revenue for the full year, $37.30B against $36.88B, which it did for the first time in FY2026.

The seasonal pattern deserves emphasis because it tempers the recovery narrative. Q4 FY2025 managed-services bookings were $12.4B at exactly the same 1.4x book-to-bill, with consulting at $8.9B and 1.0x. The shape of this quarter's bookings mix is a near-replica of last year's fourth quarter. Management's own framing is that managed services bookings are lumpy and should be read on a trailing four-quarter basis, where the book-to-bill is 1.2x.

"Managed services bookings were a record $12.8 billion after our previous record in Q4 of last year, with a book-to-bill of 1.4. Managed services bookings can be lumpy, which is why we focus on the trailing four-quarter book-to-bill, which was 1.2. Fixed price work, which includes outcome-based, is now over 65% of bookings and continues to grow."
— Angie Park, Chief Financial Officer

Assessment: the trailing 1.2x is the number to carry into the model, and it is a healthy figure. The fixed-price disclosure is the more interesting one: over 65% of bookings and rising. Fixed-price and outcome-based work transfers delivery risk to Accenture and is precisely where AI-driven productivity accrues to Accenture rather than to the client, which is the mechanical reason the AI-efficiency story can be margin-accretive rather than revenue-destructive. It is also where a delivery miss shows up as a margin hit with no pricing recourse. Management is building the structure that makes AI a tailwind and taking on the execution risk that comes with it.

By Geographic Market — Q4 FY2026

Americas — the federal recovery lands

Americas revenue grew 7% in local currency, led by high tech, software and platforms, utilities, and banking and capital markets, with growth driven by the United States. Operating income of $1,615.8M at a 17% margin compares to $1,407.5M at 16% on an adjusted basis a year ago, so the region delivered both the revenue growth and 100 basis points of margin. This is the region that carried the federal drag all year, roughly a full point of consolidated revenue, and the drag sunset at the end of Q3. Management named federal over-delivery as one of the four contributors to the quarter's upside and said federal will be "a significant contributor" in FY2027, citing the Department of War data platform win.

Assessment: the federal overhang that we flagged as unbounded at initiation in June 2025, sized at 1% to 1.5% in September 2025, and watched anniversary through FY2026, is now a tailwind. That is a complete and favorable resolution of one of the three original bear points, and it is the cleanest positive in the file. The caution is that federal strength is contract-cycle driven and the comparison base gets harder from Q1 FY2027 onward.

EMEA — growth without margin

EMEA grew 7% in local currency, led by public service, banking and capital markets, and software and platforms, with the United Kingdom and Italy the named drivers. Operating margin held flat at 13%, so $384.6M of incremental quarterly revenue delivered $70.5M of incremental operating income, an incremental margin of about 18%. For the full year EMEA grew 9% in US dollars and only 4% in local currency, the widest FX gap of the three regions, and its full-year operating margin was flat at 13% on an adjusted basis.

Assessment: EMEA is growing at the company rate and converting at the company's lowest regional margin, and the Middle East sits inside it. Management sized the Middle East business at roughly $1B annualized, said the direct impact worsened in Q4, and baked continued pressure into FY2027 guidance with no growth assumed at the top of the range. EMEA's flat margin is therefore a reasonable outcome given a deteriorating sub-region, but it leaves the region as a growth contributor rather than an earnings contributor.

Asia Pacific — the number nobody asked about

Asia Pacific grew 7% in local currency and only 3% in US dollars, and its operating income fell. Operating income of $382.4M compares to $462.8M adjusted a year ago, a 17% decline, on revenue up 3%. Operating margin was 14% against 18% adjusted, a 400 basis point compression. For the full year the pattern is the same if milder: adjusted operating income of $1,796.2M against $1,873.2M, down 4%, with margin at 17% against 19%.

Assessment: this is the only segment line in the release that is unambiguously worse than a year ago, it is the only one that went unmentioned in the prepared remarks, and it drew no analyst question. Asia Pacific is about 14% of revenue, so 400 basis points of regional margin is roughly 55 basis points of regional contribution and a meaningful offset inside a consolidated 20 basis point expansion. The likely drivers are the Japanese mid-market push, which includes the COMWARE acquisition at presumably dilutive initial margins, and the FX translation gap. Neither was confirmed. We flag it as the single most under-discussed disclosure in the print.

By Industry Group — Q4 FY2026

Assessment: the industry table is where the Q4 inflection is most visible against the full year. Health and Public Service grew 9% in local currency in the quarter against 2% for the full year, a seven-point acceleration that is the federal sunset showing up in the numbers. Resources doubled its full-year rate to 6%, which matches management's claim that the indirect Middle East drag on discretionary spend in Products and Resources stabilized. Products remains the laggard at 4% in the quarter, consistent with flat consumer-facing client budgets, and it is the largest group at 30% of revenue, which caps how fast the company can grow. Communications, Media and Technology is the only group growing double digits in both periods and is the clearest evidence that the AI re-platforming demand management describes is real where clients have money.

Key Operating Metrics

Key Topics & Management Commentary

Overall Management Tone: Confident and markedly less defensive than in June, with the posture of a team that believes it has been misread. Management led with breadth rather than with a single hero metric, stated plainly the two negatives that mattered most to the bear case (pricing weakness in Q4 and a worsening Middle East), and declined to oversell the gross-margin reversal that would have been the easiest victory lap available. Analyst questioning was unusually constructive and the only genuinely hard exchange concerned what the FY2027 guide implies about organic deceleration, where the answer was framework-level rather than quantitative.

1. Both re-engagement triggers were hit

In June we downgraded to Hold and named the two conditions for re-engagement: a total book-to-bill back above 1.1x, or gross-margin re-expansion. The quarter delivered both. Total book-to-bill was 1.2x on $22.17B of bookings. Gross margin was 32.0% against 31.9%, expanding both for the quarter and for the full fiscal year, the latter being the first full-year expansion in a couple of years on the characterisation offered during Q&A and not disputed by management. Revenue cleared the top of a guided range that management had explicitly flagged as being at risk at the low end.

The June downgrade rested on the claim that two pillars of the December 2025 upgrade had reversed and that the reversal was structural rather than cyclical. One quarter does not settle a structural question, but it does remove the evidentiary basis for the downgrade. The company's own summary of the year was unhedged.

"For the full year, we achieved or exceeded all aspects of our original guidance while returning a record level of cash to shareholders."
— Angie Park, Chief Financial Officer

Assessment: intellectual honesty requires acting on stated triggers, and the triggers were met. What the triggers did not price was the 47% rally from the June 30 closing low of $124.44 that preceded the print, which is why the rating action here is to retire the downgrade thesis rather than to re-upgrade. The fundamental condition we required is satisfied; the valuation condition that made December's upgrade attractive is not.

2. The bookings recovery, and the half of the business that carried it

Bookings went from $19.3B at a 1.0x book-to-bill in Q3 to $22.17B at 1.2x in Q4, a 15% sequential increase and the sharpest single-quarter reversal in the window we cover. The composition is where the analysis lives. Managed services contributed a record $12.77B at a 1.4x book-to-bill; consulting contributed $9.40B at 1.0x. A year ago the same quarter produced $12.4B of managed services at 1.4x and $8.9B of consulting at 1.0x. The mix shape is a near-replica.

Management was asked directly whether the Q3 deals that slipped had landed in Q4, and the answer was no.

"You saw in Q4, they went up. They went up in Q4 not because of the deals that got pushed, which will come through, we expect sometime in FY 2027, but because of the deals that we were seeing come through in Q4 came through."
— Julie Sweet, Chair & CEO

That is a better answer than the alternative. It means the Q4 bookings figure is clean of catch-up and the slipped Q3 deals remain in front of the company as FY2027 upside. It also means the FY2026 bookings total of $84.54B, up 5% in US dollars and only 3% in local currency, understates the pipeline rather than overstating it.

Assessment: the recovery is real and clean, and it is concentrated in the lumpy, longer-burn, outcome-priced half of the business. Consulting bookings grew about 6% year over year off a weak base and are back at a 1.0x book-to-bill after 1.3x in Q2 and 1.1x in Q3. The trailing four-quarter 1.2x is the honest summary statistic and it is a healthy one. For the rating, this clears the bar we set. For the thesis, it does not yet demonstrate that discretionary consulting demand has turned.

3. Gross margin re-expands, and the CFO redirects

Gross margin of 32.0% against 31.9% expanded 10 basis points in the quarter and by the same amount for the full year. Management was asked how much of the FY2027 operating-margin guide depends on gross margin, and what levers get them there. The response was notable less for the levers than for where it pointed the reader.

Q: "If you think about your gross margin profile, you turned in some gross margin expansion for the full FY 2026, which is the first time I think in a couple of years. ... how much of a component of that is gross margins? Can you expand gross margins? Can you maybe talk about some of the levers to get there, whether that be fixed price contracts, pricing, utilization or anything else?"
— James Schneider, Goldman Sachs

A: "As it relates to gross margins, so within gross margins, we were really pleased with the 10 basis points expansion for the quarter and for the year ... Importantly, our investments are predominantly embedded in gross margin. If you think about our acquisitions that we did this year, $4.9 billion, if you think about our talent and our learning that we do, our R&D, all of that, the majority of that hits gross margin. What you do not see is that our contract profitability, which expanded this year, which we were really pleased with, absorbs the massive investments that we make year in and year out. The best way to look at us is the guidance that we give for op margin."
— Angie Park, Chief Financial Officer

The substantive disclosure inside that answer is that contract profitability expanded. That is the AI-pricing-pressure metric stripped of investment noise, and it is the first time in three quarters it has been described as expanding. The rhetorical move is the closing sentence, which steers the reader from gross margin to operating margin.

Assessment: management is managing the reader away from the metric we and much of the Street use as the AI-pricing proxy, and doing so while the metric is moving in their favor. The charitable reading is that gross margin genuinely is a poor signal when $4.9B of acquisitions and $2B of R&D and training sit inside it. The less charitable reading is that a company does not usually ask you to stop looking at a number that is going up. Contract profitability expanding is the real win and it is buried in a redirect.

4. "In Q4, we saw lower pricing in many areas of our business"

Asked whether competitors are pricing more aggressively to win larger deals in an increasingly agentic market, management gave the most candid pricing answer of the six quarters we have covered.

"Look, we continue to operate in a highly competitive environment. When you think about pricing in 2026, it was overall stable, and at the same time, in Q4, we saw lower pricing in many areas of our business. As we look to FY 2027, our guidance ... assumes that we are going to have continued intense competition and our current expectations are baked in."
— Julie Sweet, Chair & CEO

Two things are true in that sentence and they point in opposite directions. Pricing was stable for the year, which contradicts the thesis that AI is already compressing rates across the book. Pricing was lower in many areas in the fourth quarter, which is the most recent datapoint and the direction of travel. The quarter in which Accenture printed above its guided range with expanding gross margin is also the quarter in which it saw pricing weaken.

Assessment: this is the live bear datapoint and management stated it plainly, which is to their credit and does not make it less serious. It also explains the shape of the FY2027 margin guide: 10 to 30 basis points, at the low end of what a 3% to 6% revenue year with a growing fixed-price mix should produce. Management has built pricing pressure into the guide rather than hoping it resolves. We treat the AI-pricing bear point as unresolved rather than reversed, and we expect gross margin to remain a quarter-by-quarter referendum.

5. The FY2027 guide: stabilization bought with acquisitions

FY2027 revenue growth of 3% to 6% in local currency compares to the 5% Accenture just delivered, so at the midpoint of 4.5% the guide is a modest step down. The more important figure came on the call rather than in the release: inorganic contribution of 2% to 2.5%. That puts guided organic growth at roughly 0.5% to 4%, against roughly 3% organic in FY2026. At the midpoint, organic growth is guided to decelerate.

Management's framing for the variability inside the range is explicitly about discretionary spend and the Middle East rather than about large-deal demand.

"With respect to discretionary spend at the top end of the range, we have allowed for a stable to slightly improving discretionary spend environment, while at the bottom, we allow for deterioration."
— Angie Park, Chief Financial Officer

Published consensus revenue of about $76.44B sits essentially at the floor of the guided range, while published consensus EPS of about $14.63 sits just above the $14.60 guidance midpoint. The Street is modelling low-end revenue with better-than-guided conversion.

Assessment: the guide is a stabilization, not a re-acceleration, and the stabilization is purchased. Two to two and a half points of the 3% to 6% comes from acquisitions, and management plans roughly $5B more of them in FY2027 on top of the $3B of cyber operational-technology deals that just closed. That is a coherent strategy for a company whose organic engine is running at 2% to 3%, and it is also the definitional statement that the organic engine is running at 2% to 3%. The October 14 investor day is where management says it will frame the multi-year algorithm, and that is the event that should set the multiple.

6. The $5B debt raise and the end of the net-cash balance sheet

Accenture completed a $5B debt offering in the fourth quarter, taking long-term debt from $5.03B to $9.999B. Cash finished at $12.83B against $11.48B. Net cash, including short-term investments and current debt, fell from about $6.34B a year ago to about $2.73B. Interest income less interest expense went from $39.0M of net income in Q4 FY2025 to a $0.4M net expense in Q4 FY2026, the first negative net-interest quarter in years, and that reflects roughly seven weeks of the new issuance. Adding other expense, net, the full non-operating line swung from $25.5M of income to $65.4M of expense.

The non-operating drag is already visible in the EPS bridge, where lower non-operating income subtracted $0.11 from the quarter, with net interest about $39M of the $91M pre-tax swing and other expense the rest. FY2027 will carry twelve months of a $10B debt balance against a tax-rate range of 24.5% to 26.5%, compared to 24.9% adjusted in FY2026.

Assessment: this is the mechanical answer to why a 3% to 6% revenue guide with 10 to 30 basis points of margin expansion and a 3% share-count reduction produces only 3% to 6% EPS growth. Interest expense and a potentially higher tax rate absorb essentially all of it. The strategic logic for the raise is defensible, since the capital funds acquisitions into higher-growth, non-labor-leveraged areas. But the balance sheet is no longer the fortress it was, and the earnings algorithm has lost the free optionality that net cash provided. In June we flagged that the model needed a debt-service line introduced; it is now sized.

7. Capital return: management bought the bottom

Accenture returned a record $11.5B in FY2026, up 38%, comprising $7.5B of repurchases and redemptions and $4.0B of dividends. The fourth quarter alone carried $2.3B of buyback, which was the incremental $2B management added above its own "at least $9.5B" commitment. The execution price is the story.

"In the fourth quarter, we repurchased 17.6 million shares for $2.3 billion at an average price of $131.89 per share."
— Angie Park, Chief Financial Officer

The stock's 52-week closing low, set on June 30 after the June print, was $124.44. An average execution of $131.89 on $2.3B of capital is within about 6% of the bottom. This is the second consecutive year management has accelerated repurchase into weakness: the December 2025 quarter bought $2.3B at an average $245.32, and FY2026 as a whole retired 39.9 million shares for $7.5B. FY2027 commits to at least $9.5B, roughly 75% of operating cash flow, split between $5.5B of repurchases and dividends growing 5% per share, with weighted average share count guided down about 3%. Remaining authority is roughly $7B after the board added $6B in September 2026.

Assessment: capital allocation is the pillar of this thesis that has never wavered and the one that has most consistently earned its place. Two caveats temper it. The dividend step-up decelerates from 10% to 5%, which matters because the income case was part of the downside support we leaned on in June. And $9.5B of return plus roughly $5B of acquisitions plus the $3B of cyber deals closing in Q1 against $11.0B to $11.8B of free cash flow means FY2027 is funded partly from the balance sheet again. The buyback-versus-M&A funding tension we flagged in June has not been reconciled; it has been resolved in favour of doing both with debt.

8. Headcount, revenue per person, and the first explicit AI hiring statement

Headcount reached approximately 814,000, up about 5% year over year, which sits awkwardly beside the stated pivot toward non-full-time-equivalent commercial models and the premise that agentic AI reduces delivery labour. Management was pressed on exactly that contradiction and gave the clearest statement yet on where AI lands in the cost base.

Q: "We're kind of pushing for this non-FTE kind of commercial model and just trying to reconcile that with the growth in headcount that was up 5%. To be honest with you, I thought with agentic we'd be probably decreasing headcount."
— Bryan Keane, Citi

A: "We're experiencing a lot of demand in new areas... You are seeing an increase in revenue per person, which is what you would expect in part due to AI. We're also in growth mode. When we look at next year, we expect to hire in every market, but it will be below what we've been hiring this year... Next year, we do expect to hire, but it will be at a lower rate, in part due to AI."
— Julie Sweet, Chair & CEO

Management also disclosed that it now has nearly 110,000 AI and data professionals, exceeding a three-year goal to double that workforce from 40,000 to 80,000 by the end of FY2026, and that employees completed 46 million hours of training during the year against $1B of learning and development spend.

Assessment: "we do expect to hire, but it will be at a lower rate, in part due to AI" is the first time in our coverage window that management has attributed a hiring deceleration to AI on the record. Read as a margin statement it is positive: rising revenue per person with slower headcount growth is the nonlinear-growth outcome the bull case requires. Read as a revenue statement it is the bear case stated by the company, because in a labour-leveraged business headcount is capacity and capacity is the revenue ceiling. Both readings are correct, and which one dominates depends entirely on whether the non-FTE revenue being built through acquisition scales faster than the labour revenue decelerates. That is the central question for the investor day.

9. A $1B AI-safety build, and selection by a frontier lab

The most concrete new disclosure on the call was a five-year, $1B investment to build an AI-safety business, including a dedicated safety lab and team, anchored by the Faculty acquisition completed earlier in FY2026 and validated by a frontier-lab customer.

"Our acquisition of Faculty earlier this year was driven in part because they have deep safety experience... Safety is a big component of what all of the enterprises have to do... Anthropic selected us for our AI expertise, our security expertise, our AI safety expertise. That relationship is non-exclusive and in fact it is important that we continue to actually work with multiple labs... Of course, we are not going to comment specifically on any particular contract, but we are investing $1 billion over the next five years to build out that safety business, including a safety lab and the team."
— Julie Sweet, Chair & CEO

Management declined to size the Anthropic relationship, its duration, or its economics, and declined to say whether other labs have made inbound inquiries.

Assessment: this is the cleanest strategic reframing of AI from threat to revenue that Accenture has produced. Enterprise AI governance and safety is non-discretionary work driven by regulation and board risk committees rather than by IT budget cycles, it is advisory and therefore high-rate, and it is not automatable by the technology it governs. A frontier lab selecting Accenture for safety work is a credibility marker that no amount of slide-ware delivers. The $1B over five years is a modest $200M annual run-rate against $74B of revenue, so this is optionality, not an earnings driver. We would want the investor day to size the opportunity rather than the investment.

10. Tokenomics: deflation reframed as demand

The question of whether falling token costs help or hurt a services business is the structural version of the AI debate, and management answered it as a demand argument rather than a pricing argument.

"You are seeing token costs go down... The way we think about the dynamic is the more that tokens go down over the next couple of years, the more it is going to enable companies to use AI in more places and at scale. To use AI, they need to change their processes, reinvent their work, build out that AI stack in order to really do it, and all of that is what clients are turning to us. The more change there is, the more they turn to us."
— Julie Sweet, Chair & CEO

On client budgets specifically, management declined to forecast: calendar-year clients are only beginning their FY2027 budget cycles, so visibility arrives in January and February. The guide assumes "more of the same."

Assessment: the argument is a Jevons-paradox claim and it is the correct one to make, because it has been right in every prior technology cycle Accenture has monetised. It is also unfalsifiable on a one-quarter horizon, which is why it keeps appearing. The testable version of the claim is the FY2027 organic growth rate, and management has guided that to roughly 0.5% to 4%. If cheaper tokens are generating more change and more change means more Accenture, organic growth should be accelerating rather than decelerating. It is not yet.

11. Renewal economics described as "steady"

Asked specifically how much AI-driven deflation is baked into like-for-like renewals in the FY2027 guide, management characterised the effect as unchanged from historical norms.

"We are definitely giving more productivity due to AI. Overall, though, the impact has been steady. We're offsetting as we have in the past with new kinds of work, more scope, et cetera. Absolutely giving more AI efficiencies and more than offsetting that as a whole."
— Julie Sweet, Chair & CEO

Assessment: "more than offsetting that as a whole" is the strongest single sentence available to the bull case, because it addresses the cannibalisation mechanism directly rather than through a growth-opportunity analogy. It is also assertion rather than evidence, and it sits in the same call as the acknowledgement that Q4 pricing was lower in many areas. We would weight it more heavily if the offsetting scope were visible in consulting bookings, which sit at a 1.0x book-to-bill.

12. The Middle East and the shape of the range

The Middle East was the acute negative of the June quarter and it did not improve. Management sized the business and described the Q4 trajectory plainly: the direct impact "continued to be a headwind and in fact worsened in Q4," while the indirect drag on discretionary spending in Products and Resources stabilised.

"The Middle East, let me just remind you, it is roughly about $1 billion on an annualized basis... We do expect that to continue, and we baked that in. Overall, the top end of the range does not assume any growth, and the bottom end of the range allows for deterioration."
— Angie Park, Chief Financial Officer

Assessment: sizing the exposure at roughly $1B, about 1.3% of revenue, converts an open-ended geopolitical overhang into a bounded one, which is the same favourable transformation the federal drag went through over FY2026. Assuming no growth at the top of the range is genuine conservatism. The anniversary arrives in the third quarter of FY2027, so the drag is a first-half issue. This is now a manageable, quantified, time-boxed headwind rather than a thesis risk.

Guidance & Outlook

Q1 FY2027

The shape of this guide is the inverse of June's. In June, revenue was cut, EPS was protected and cash return was raised, which told you management would defend the bottom line through a soft top line. Here, revenue growth is guided to a range whose top end is above what FY2026 delivered, margin expansion is maintained at 10 to 30 basis points, and the capital-return commitment is set at a level below what FY2026 actually returned. Management is guiding to growth and taking the cash-return number down from a record that was itself an overshoot.

Implied quarter-over-quarter ramp: at the FY2027 revenue midpoint of roughly $77.5B and a Q1 midpoint of roughly $19.28B, the remaining three quarters need to average about $19.4B, a sequential build of less than 1% per quarter. That is an undemanding path. It is also a path with no margin for error if discretionary spending deteriorates, because the entire range is only $2.2B wide and the acquisition contribution alone is $1.5B to $1.9B of the guided growth.

Street at: published consensus of roughly $76.44B of FY2027 revenue sits essentially at the floor of the guided range, implying about 3% local-currency growth. Published consensus EPS of roughly $14.63 sits marginally above the $14.60 guidance midpoint. The Street is therefore modelling the low end of revenue with slightly better conversion than guided, which is a defensible posture given that FY2026 met or beat every line of its own original guide.

Guidance style: Accenture guides conservatively and finishes near or above the top. FY2026 was guided at +3% to +4% local currency in June and finished at +5%; adjusted EPS was guided at $13.78 to $13.90 and finished at $13.97; free cash flow was guided at $10.8B to $11.5B and finished at $11.62B. Applying that pattern to a 3% to 6% FY2027 guide points toward the upper half. The offset is that the FY2027 range is unusually wide for a first guide and the width is explicitly attributed to discretionary spend and the Middle East, which are macro variables management cannot control.

Analyst Q&A Highlights

What actually drove the upside, and whether it repeats

The opening question went straight to the quality of the beat: what drove the over-delivery, what surprised, and what it implies for FY2027. Management named four contributors and immediately de-weighted all of them, which was a deliberate choice. One of the four, a decision to let employees carry paid time off forward, is a capacity timing benefit rather than a demand event, and it will not repeat on the same terms.

Q: "I want to get a little bit more detail on maybe what drove the upside in the quarter and any surprises across the three months as you saw the quarter play out and how does that result inform the outlook here in FY 2027?"
— Tien-Tsin Huang, JPMorgan

A: "When you think about the over-delivery above the 5% at the top of our guided range, it was a number of factors. We saw an uptick in small deals. We were able to mobilize faster for some of the new contracts. Some of our acquisitions in our federal business over-delivered, and we allowed our people to carry over PTO, which meant we had people for the demand."
— Julie Sweet, Chair & CEO

Assessment: the honesty is useful and the content is mixed. An uptick in small deals is demand, faster mobilisation is execution, federal over-delivery is a contract cycle, and PTO carry-forward is borrowed capacity. The follow-up disclosure that "no one factor was material in the outperformance" means none of these individually explains a 3.6% revenue beat, which argues for broad execution rather than a single lucky item. It also means none of them is a repeatable growth driver, which is consistent with a guide that steps organic growth down rather than up.

Why the FY2027 guide implies organic deceleration

The hardest exchange of the call. The question put the deceleration directly on the table and asked what management saw in the quarter that warranted additional conservatism, plus what moves the outcome between the low end and the high end. The answer was a list of strengths followed by a macro framework, and it never named an organic growth number.

Q: "Maybe just go a little further into the guide now, just because it does imply an organic deceleration. Maybe just help us understand what you saw this quarter that you want to build in a little more conservatism around in the year ahead. If you could also just touch on the variability in the guide, what factors would lead to the low end versus the midpoint or the high end?"
— Darrin Peller, Wolfe Research

A: "We just posted $85 billion in bookings, and that included 141 clients with quarterly bookings over $100 million. We see backlog. We see the big deals from those large deals layering in. Our pipeline is solid, and we see continued demand for those large deals. As it relates to the macro overall, we expect that dynamic to continue, but with respect to discretionary spend at the top end of the range, we have allowed for a stable to slightly improving discretionary spend environment, while at the bottom, we allow for deterioration."
— Angie Park, Chief Financial Officer

Assessment: the question asked why organic decelerates and the answer explained why the range is wide. Those are different questions. Management did confirm that the entire range width is discretionary-spend-driven rather than large-deal-driven, which is a useful disclosure, because it means the backlog-funded base of FY2027 is secure and the variable is the project work layered on top. The refusal to frame organic growth explicitly, for the second consecutive quarter, is the most conspicuous omission on the call and is presumably reserved for the October 14 investor day.

Whether competitors are pricing more aggressively

A recurring theme across the quarter's sell-side notes is whether agentic delivery models let challengers underprice incumbents on large deals. Management answered with a year-level characterisation and a quarter-level one that point in opposite directions, and then confirmed the FY2027 margin guide already absorbs the pressure.

Q: "Maybe just touch for a moment on pricing in the competitive landscape today. Are you seeing any competitors price more aggressively to win contracts, especially larger deals, in the context of some of the changes happening around obviously becoming more agentic?"
— Darrin Peller, Wolfe Research

A: "Look, we continue to operate in a highly competitive environment. When you think about pricing in 2026, it was overall stable, and at the same time, in Q4, we saw lower pricing in many areas of our business. As we look to FY 2027, our guidance ... assumes that we are going to have continued intense competition and our current expectations are baked in."
— Julie Sweet, Chair & CEO

Assessment: the most important sentence in the entire call for the structural thesis, and it is a concession. Pricing weakened in the most recent quarter even as revenue beat and gross margin expanded. Management has chosen to guide margin conservatively rather than assume the pressure abates, which is the right posture and also an admission that they do not expect it to abate. The AI-pricing bear point is not reversed; it is being managed.

Reconciling 5% headcount growth with the non-FTE pivot

The structural contradiction in the Accenture story is that a company pivoting to non-labour commercial models and talking about agentic delivery grew headcount 5%. The answer produced the first on-record attribution of a hiring deceleration to AI.

Q: "We're kind of pushing for this non-FTE kind of commercial model and just trying to reconcile that with the growth in headcount that was up 5%. To be honest with you, I thought with agentic we'd be probably decreasing headcount. Just trying to reconcile those two factors going forward."
— Bryan Keane, Citi

A: "We're both upskill and hiring in data and AI. At the same time, and you saw that we increased revenue per person this year... When we look at next year, we expect to hire in every market, but it will be below what we've been hiring this year. Very importantly, we still expect to hire more entry-level... Next year, we do expect to hire, but it will be at a lower rate, in part due to AI."
— Julie Sweet, Chair & CEO

Assessment: a genuinely informative answer and a two-edged one. Rising revenue per person with decelerating headcount growth is the nonlinearity the bull case needs, and the commitment to keep hiring entry-level while redefining entry-level work is the honest version of the pyramid problem. The bear reading is that in a labour-leveraged business, slower capacity growth caps revenue growth, which is exactly what the FY2027 organic guide shows. Management is not hiding this; they are telling you the model is changing and asking you to trust that the non-FTE revenue scales fast enough.

Whether the slipped Q3 deals landed in Q4

June's bookings rollover was partly attributed to managed-services deals slipping. The obvious question is whether the Q4 record is simply those deals arriving late, which would make the recovery a timing artefact rather than a demand signal. Management said it was not.

Q: "Just thinking about the managed services bookings in particular. That was a source of softness in the third quarter. It sounded like a couple of deals in particular were pushed, and then it was a source of strength this quarter. Just wondering, timing, did any of those deals come actually into the fourth quarter?"
— Bryan Keane, Citi

A: "They went up in Q4 not because of the deals that got pushed, which will come through, we expect sometime in FY 2027, but because of the deals that we were seeing come through in Q4 came through. That is just the nature of our business... which is why we do not guide to bookings. We really focus on revenue."
— Julie Sweet, Chair & CEO

Assessment: the best answer of the call, and verifiable against the numbers rather than merely assertive. If the slipped deals did not land, the $22.17B is clean and those deals remain FY2027 upside not yet in the guide. The caveat management attached is also worth taking seriously: they do not guide bookings and they do not want bookings treated as the forecast. We will keep treating the trailing four-quarter book-to-bill, now 1.2x, as the leading indicator, because for a backlog business it is.

How much AI-driven deflation is embedded in renewal pricing

The sharpest framing of the cannibalisation question anyone asked: not whether AI creates opportunity, but how much like-for-like price erosion is assumed in the FY2027 guide when a contract renews with AI-delivered productivity.

Q: "With AI, there has been some deflationary forces. When you think about the guidance associated with FY 2027, how are you thinking about the impact of AI on sort of like for like renewals and the amount of deflation that you're baking into those due to AI?"
— Keith Bachman, BMO Capital Markets

A: "We are definitely giving more productivity due to AI. Overall, though, the impact has been steady. We're offsetting as we have in the past with new kinds of work, more scope, et cetera. Absolutely giving more AI efficiencies and more than offsetting that as a whole."
— Julie Sweet, Chair & CEO

Assessment: management claims full offset, which is the central bull assertion stated as plainly as it can be. The weakness is that "steady" and "more than offsetting" are characterisations, not disclosures, and they sit in the same call as the pricing concession. The place this claim would show up if true is consulting bookings, which sit at 1.0x. Treat it as management's view, directionally supported by expanding contract profitability and not yet corroborated by the bookings mix.

Competition from forward-deployed-engineer models

A line of questioning on whether Palantir's forward-deployed-engineer approach, and software vendors copying it, erodes the systems-integrator position. Management reframed the threat as a distribution opportunity, which is the structurally correct answer if the claim about scale holds.

Q: "As you think about the competitive environment, I just wanted to see if you could comment on Palantir and the role of FDEs and how that's influencing the market. It's not just Palantir. Also, the software companies are deploying more forward-deployed engineers."
— Keith Bachman, BMO Capital Markets

A: "It's a great opportunity... the FDE model is a growth opportunity for us because we can scale FDEs... Keep in mind that FDEs are used a lot with the sort of new pioneering things, and then it becomes something of it's a repeatable offering. What Accenture can do with all of these partners, right, is we can help them have more FDEs because we're training and delivering more FDEs as part of our partnerships. Then as we create those new solutions, we have then the scale to go repeat them and take them to multiple clients."
— Julie Sweet, Chair & CEO

Assessment: the pioneer-then-industrialise argument is Accenture's historical pattern and it has worked through cloud, through ERP, and through digital. The structural question the answer sidesteps is margin: forward-deployed engineering is high-touch, scarce-skill work with a different cost curve than offshore delivery, and the economics of being the scaling partner for someone else's pioneering model are not obviously better than the economics of being the pioneer. The answer is strategically sound and economically unquantified.

Why acquisition spend is rising faster than the revenue it contributes

The closing question was the sharpest valuation question of the call: the cost of acquisitions appears to be rising relative to the revenue they contribute, which either means Accenture is overpaying or it is buying faster-growing assets. Management said the latter and offered a datapoint.

Q: "Acquisition spend relative to revenue contribution is a little higher. So the cost of acquisitions seem a little higher. Is that related to faster revenue growth over the next few years from the acquisitions themselves? ... Are the underlying acquisition that you're making growing faster than maybe some of the acquisitions you've made in the past?"
— David Koning, Baird

A: "The answer is yes. Our acquisition spend is putting us into new areas like data centers. Our data center acquisition, DLB, is growing very high single digits. I'm sorry, very high double digits. ... Remember, what we always are thinking about, is how do we scale in the areas that are growing now that if we scale inorganically, it's going to drive more organic growth because we can do it faster, but we also use them to expand into these areas that start small and then grow. ... You're not going to see them as big a contribution maybe in the first couple of years, but as we scale, it sets us up for that long-term growth."
— Julie Sweet, Chair & CEO

Assessment: the admission embedded in the answer is that the acquisitions are dilutive to near-term growth contribution relative to their cost, and that the payoff is a multi-year scaling story. That is a reasonable strategy and an expensive one to be asked to underwrite at 14.5x forward earnings. Goodwill rose $4.3B this year to $26.8B, acquisition spend rose from $1.5B to $4.9B, and another $8B is committed across FY2027 counting the cyber transactions. The company is converting balance-sheet capacity into future growth optionality. Investors are being asked to pay for that optionality now and see the organic result later, with the first real accountability checkpoint at the investor day.

What They're NOT Saying

1. Still no quantified FY2027 organic growth framework. This is the second consecutive quarter management has supplied the building blocks (2% to 2.5% inorganic, federal returning to growth, slipped deals landing sometime in FY2027, Middle East flat at the top of the range) while declining to put an organic number around them. The question was asked directly and answered with a bookings recital and a macro framework. Investors are being asked to wait thirteen days for the investor day to learn the rate at which the core business actually grows.
2. Asia Pacific's margin collapse went entirely unmentioned. Fourth-quarter Asia Pacific operating income fell 17% on revenue up 3%, and regional operating margin was 14% against 18% adjusted a year ago. It appears nowhere in the prepared remarks and no analyst raised it. For a region that is 14% of revenue, 400 basis points is a material offset inside a consolidated 20 basis point expansion, and the probable causes (the Japanese mid-market push, including the COMWARE acquisition, plus translation effects) were never confirmed.
3. The fourth-quarter cash print was not addressed. Operating cash flow fell 21% year over year and free cash flow fell 25%, while days services outstanding rose to 50 from 47 a year ago and 48 last quarter, the second consecutive increase. The full-year cash numbers are excellent and were discussed at length. The quarter's deterioration and the DSO trend received a single factual mention and no explanation.
4. The advanced-AI bookings metric remains retired, and the ecosystem disclosure is now being consolidated too. The specific advanced-AI bookings dollar figure disappeared last quarter and did not return; this quarter offered "nearly 100 additional clients" and "more than 400" for the year instead. Management also announced that the top-ten ecosystem partner reporting and the emerging AI and data partner reporting will be merged into one group and disclosed annually rather than quarterly from FY2027. Both changes reduce the frequency and granularity of the disclosures the market uses to test the AI growth claim, and both arrive while the claim is contested.
5. No sizing on the Anthropic relationship or the AI-safety revenue opportunity. Management sized its own investment at $1B over five years and declined to size the contract, its duration, its economics, or whether other frontier labs have made inbound inquiries. The question explicitly asked about inbound inquiries from other labs and that part went unanswered. Disclosing the spend and withholding the return is the pattern of a business that is not yet material.
6. No pro-forma leverage or interest-expense framework after the $5B raise. Long-term debt doubled to $10.0B, net cash halved to roughly $2.73B, and net interest turned negative in the quarter. Management gave no FY2027 interest-expense figure, no leverage target, and no statement on whether further issuance funds the roughly $8B of FY2027 acquisition commitments. The FY2027 EPS guide absorbs the cost without naming it.
7. The capital-allocation arithmetic was not reconciled. At least $9.5B of shareholder return plus roughly $5B of planned FY2027 acquisitions plus roughly $3B of cyber transactions closing in Q1 totals about $17.5B against guided free cash flow of $11.0B to $11.8B. Nobody asked how the $6B gap is funded, and management did not volunteer it. The answer is presumably the balance sheet and further debt, which is a material change in financial policy delivered without comment.
8. No acknowledgement of competitive loss to AI-native firms. Asked twice about competition, once on aggressive pricing and once on forward-deployed-engineer models, management spoke only to its own share gains and partnership positioning. Pricing was conceded as lower in many areas in Q4; the identity of who is pricing lower was not. The sell-side downgrades into this print were built on exactly that question.
9. The PTO carry-forward was named and not quantified. Allowing employees to carry paid time off forward provided delivery capacity that supported the revenue beat. Management said no single factor was material, which bounds it, but did not size it, and did not say whether the carried balance is a FY2027 capacity drag when it is taken.

Market Reaction

• Pre-print setup: ACN closed at $183.37 on September 30, down 31.7% year to date against the S&P 500's +11.8%, down 24.8% over the trailing twelve months, and down 2.5% over the trailing thirty days. The 52-week closing range entering the print was $124.44 to $288.54, so the stock sat roughly 36% below its 52-week high and about 47% above its low. The September 30 session itself was telling: +3.5% on 10.54 million shares, roughly twice the prior thirty-session average of 5.0 million, a second straight gain after five consecutive down sessions.
• Reaction session: the stock gapped open at $215.98, +17.8% against the prior close, ran to an intraday high of $227.63 (+24.1%), then faded to a session low of $211.04 and closed at $212.30, up 15.8% (+$28.93). Volume of 28.8 million shares was more than five times the thirty-session average.
• Benchmark: the S&P 500 rose 0.2% on the session, so essentially the entire move is idiosyncratic.
• Technical context: the close sits about 20% above the 50-day moving average of $177.45 and about 8% above the 200-day of $196.59, having closed below the 200-day in every session of the past four months.

This is a sentiment event, not a numbers event. A 3.6% revenue beat and a 3.5% EPS beat do not produce a 16% move in a $130B company. What produced it is that the two things the market had decided were structurally broken, bookings and gross margin, both printed fine, and the FY2027 guide did not contain the organic-growth capitulation that positioning implied was coming. The stock had already rallied roughly 47% from its June 30 closing low of $124.44 into the print, and the sell-side had responded to that rally by raising price targets and, in two cases out of six surveyed, cutting ratings. Published targets clustered between $175 and $200. The stock closed above all of them except one.

The intraday fade is the detail worth watching. Opening at $215.98, trading to $227.63, and closing at $212.30 means the session high was rejected and the stock finished below its own open. On a day with more than five times normal volume, that pattern is consistent with gap-up supply from holders who were waiting for a level to exit, and with fast money taking the move rather than building a position. It does not invalidate the print. It does suggest the re-rating has already found its first resistance, and it is the specific reason we are unwilling to chase the stock up 16% on the day the thesis repair was confirmed.

The setup also explains the asymmetry of the reaction. Entering the print the stock was priced at roughly 13.1 times trailing adjusted earnings with a 3.6% dividend yield, levels that embed a terminal-decline assumption for a business compounding free cash flow at 1.4 times net income. Clearing a low bar on a de-rated multiple produces exactly this kind of move. The corollary is that the next bar will be higher, and the first test is the October 14 investor day.

Street Perspective

Debate: did this print resolve the AI-cannibalisation question or just defer it?

Bull view: the bull case being made on the Street is that this quarter is the proof. Gross margin expanded for the quarter and the year, contract profitability expanded, bookings recovered to a 1.2x book-to-bill with a record managed-services quarter, revenue beat the top of the guided range on broad 7% local-currency growth in every market, and management stated that AI efficiencies are being "more than offset" by new scope. If agentic AI were eating the services model, none of those six things would be true simultaneously. The de-rating to 13 times was pricing a structural break that the numbers refuse to show.

Bear view: the bear camp contends the quarter resolves nothing because every favourable datapoint has an asterisk. The bookings recovery is managed-services-led with consulting back at a 1.0x book-to-bill, which is a near-replica of last year's Q4 mix rather than a demand inflection. The gross-margin expansion is 10 basis points, inside the noise band, and the CFO spent her answer redirecting attention away from it. Management conceded that Q4 pricing was lower in many areas. And the FY2027 guide steps organic growth down, not up, with 2 to 2.5 points of it purchased. A company winning the AI transition does not need to buy two points of growth.

Our take: the bear has the better of the specifics and the bull has the better of the direction. The asterisks are all real and the pattern they form is a business that is holding its economics rather than one that is being disrupted, which is a materially better outcome than the June tape implied. The genuinely decisive datapoint would be consulting bookings above a 1.1x book-to-bill with consulting revenue growth at or above company average for two consecutive quarters. We have one quarter of the revenue half and none of the bookings half. The question is deferred, and it is deferred from a better starting position.

Debate: is the acquisition programme building the future or papering over the present?

Bull view: some sell-side desks argue the M&A programme is the single most underrated element of the story. Accenture deployed $4.9B across 17 deals in FY2026, is closing roughly $3B of cyber operational-technology assets in Q1 FY2027, and plans roughly $5B more during the year, all of it aimed at non-full-time-equivalent commercial models, platforms, and intellectual property rather than at headcount. Ookla, Faculty, Dragos, and the data-centre business are revenue that does not scale with people, which is precisely the structural answer to the labour-leverage problem. Management says these assets grow faster than the company and that the contribution builds over years rather than quarters.

Bear view: the bear camp contends this is growth laundering. Goodwill rose $4.3B to $26.8B in a single year, the company took on $5B of debt and halved its net cash to fund it, acquisition spend tripled while contributing only 2 to 2.5 points of FY2027 growth, and management conceded that the cost of acquisitions is rising relative to near-term revenue contribution. A business whose organic engine is compounding at 2% to 3% and which must buy two points to guide to 4.5% is reporting an inorganic growth rate dressed as a total one. The interest expense is permanent; the growth contribution is promised.

Our take: both are describing the same fact with different verbs, and the fact is that organic growth is roughly 3% and the acquisitions are what get reported growth to the mid-single digits. Where we side with the bull is on asset selection: buying non-labour revenue is the correct response to a labour-pricing threat, and Accenture's track record of industrialising acquired capability through Song, cloud, and supply chain is genuinely strong. Where we side with the bear is on accountability: the strategy consumes the balance sheet now and is measurable only in several years. That combination is worth paying for at 9 times earnings and is a fair price at 14.5 times.

Debate: does 14.5 times forward earnings leave anything on the table?

Bull view: a growing consensus view post-print is that Accenture at the mid-teens is still mispriced. The company guides to $11.0B to $11.8B of free cash flow on a roughly $130B market capitalisation, a free-cash yield of about 8.8% at the midpoint, with free cash flow converting at 1.2 to 1.3 times net income, a 3% annual reduction in share count, a 3.2% dividend yield growing 5%, and 10 to 30 basis points of margin expansion. That is a high-single-digit to low-double-digit total return before any multiple expansion, from a business with 317 of the world's largest companies as its deepest relationships. The 2024 multiple was above 25 times; the five-year path back to 18 times alone is worth about 24%.

Bear view: the bear camp contends the re-rating is already done and the fundamentals have not changed enough to justify more. The multiple on the FY2027 guidance midpoint went from 12.6 to 14.5 times in a single session on a guide whose EPS growth is 3% to 6%. The dividend increase decelerated from 10% to 5%. Capital return is guided below what FY2026 actually delivered. Interest expense is new and permanent. And the stock closed above every surveyed price target but one, which means the next buyer is paying up past where the sell-side thinks fair value sits, into an investor day that must deliver a credible multi-year organic framework or the multiple goes back out.

Our take: the bear has it on a twelve-month view and the bull may well be right on a three-year one. A 3% to 6% EPS guide plus a 3.2% dividend yield is roughly a market-level total return from here, and our rating framework defines that as a Hold. The free-cash-yield argument is the strongest bull point and it is partly an artefact of conversion above 1.3 times that management has guided down to 1.2 to 1.3 times. We would be buyers again on a pullback toward the low $190s, which restores a 13 times multiple, or on an investor-day framework that puts organic growth credibly back toward mid-single digits.

Model Update Needed

Valuation impact: at the $212.30 close, Accenture trades at roughly 15.2 times FY2026 adjusted EPS of $13.97 and roughly 14.5 times the FY2027 guidance midpoint of $14.60, with a 3.2% dividend yield on the newly declared $1.71 quarterly rate. The June framework of 10 to 12 times FY2027 earnings is obsolete: it was built on a broken bookings trend, a reversing gross margin, and a cut guide, and all three of those conditions have been repaired. We move the framework to 13 to 16 times the FY2027 guidance midpoint, a band of roughly $190 to $234 with a midpoint near $212. Against the $212.30 close that is about 11% of downside to the band's floor and about 10% of upside to its ceiling, with the stock sitting essentially at the midpoint. The band's lower bound is supported by the free-cash yield and the capital-return programme; its upper bound requires an investor-day framework that credibly returns organic growth to the mid-single digits.

Thesis Scorecard Post-Earnings

Overall: thesis repaired on fundamentals, weakened on price. Both pillars whose reversal drove the June downgrade have turned back up, and the federal bear point is now fully and favourably resolved, so the specific case for the downgrade no longer stands. What has not improved is the growth algorithm, which FY2027 guidance confirms is running at roughly 3% organic and reaching the mid-single digits only with purchased revenue, nor the earnings quality, where a 3% share-count reduction and 20 basis points of margin buy only 3% to 6% of EPS growth because interest and tax take the rest. The structural AI question is deferred from a better starting position rather than answered.

Action: Maintain Hold. We are not re-upgrading into a 16% single-session move that carried the stock from 12.6 times to 14.5 times the FY2027 guidance midpoint and through the entire surveyed sell-side target range, when the guide it re-rated on steps organic growth down. We are also not trimming: the capital-return programme, the 8.8% free-cash yield at the guidance midpoint, and a repaired bookings and margin trend make this a patient hold rather than a source of funds. Two paths get us back to Outperform. The first is the October 14 investor day delivering a credible multi-year organic framework that returns core growth toward the mid-single digits, which would justify 16 times and above. The second is a pullback toward the low $190s, which restores 13 times and the asymmetry we require. A consulting book-to-bill back above 1.1x alongside at-or-above-company consulting revenue growth for two consecutive quarters would do it on fundamentals alone.